Inossia

Inossia is conducting one of the largest randomized multi-center clinical trials comparing traditional bone cement with their proprietary cement softener in vertebral augmentation procedures. The trial spans 9 hospitals across Spain, Poland, Germany, and Canada with 196 participants. The aim is to demonstrate a reduction in new fractures by using the Inossia Cement Softener. Full results are anticipated in Q2 2025. Early feedback from clinicians indicates good patient outcomes with early pain control and functional recovery; no significant differences in surgical technique or complications have been observed compared to standard cements